Related Experiment Video
Updated: Mar 9, 2026
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
19.7K
Defining pharmaceutical systems strengthening: concepts to enable measurement
Health Policy and Planning
|December 28, 2016
Summary
This study defines pharmaceutical systems and their strengthening for better measurement. It proposes a holistic framework with seven critical components for assessing progress in improving access to medicines and health outcomes.
Area of Science:
- Health Systems Strengthening
- Pharmaceutical Policy and Management
Background:
- Existing tools for assessing pharmaceutical systems have a narrow focus, limiting the evaluation of interventions.
- There is a lack of a conceptualized definition for pharmaceutical systems and their strengthening, hindering measurement of progress.
Purpose of the Study:
- To define pharmaceutical systems and pharmaceutical systems strengthening (PSS).
- To propose a framework for measuring PSS by identifying critical components.
Main Methods:
- Comprehensive literature review on pharmaceutical systems definitions, frameworks, and assessment tools.
- Consultation with pharmaceutical experts to refine concepts.
Main Results:
- A proposed definition of a pharmaceutical system encompassing structures, people, resources, processes, and their interactions.
- A proposed definition of PSS as a process for coordinated, sustainable improvements.
- Identification of seven critical components for measuring PSS: products/services, policy/governance, regulatory systems, R&D/manufacturing/trade, financing, human resources, and information.
Conclusions:
- The proposed holistic definitions provide clarity on pharmaceutical systems and PSS.
- The identified components offer a practical starting point for measuring PSS progress and enhancing health outcomes.
Keywords:
Access and utilizationmonitoringpharmaceutical productspharmaceutical systemsystems strengtheningMore Related Videos
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
13.5K
07:05Correlative Optical Spectroscopy and Mass Spectrometry Imaging Methodology to Visualise Drug Distribution in a Soft Tissue Section
Published on: June 20, 2025
1.5K
Related Concept Videos
01:20Measurement of Bioavailability: Pharmacodynamic Methods
936
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
936
01:22Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
307
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
307
01:14Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
65
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A...
65
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
395
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
395
01:28Biopharmaceutics and Pharmacokinetics: Overview
4.8K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
4.8K
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
266
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
266